[DOI] [PubMed] [Google Scholar] 187.Chimerel C., Emery E., Summers D.K., Keyser U., Gribble F.M., Reimann F
As the only diabetes treatment approved by the FDA to reduce the risk of cardiovascular death, JARDIANCE represents a tremendous step forward in our efforts to reduce the impact of heart disease among adults with type 2 diabetes and cardiovascular disease, said Paul Fonteyne, president and CEO, Boehringer Ingelheim Pharmaceuticals, Inc
The real challenge now is not proving that these drugs work
Physicians and health systems that take proactive steps now to tighten their screening, monitoring, and patient education practices will be far better positioned when claims do arrive
I have, of course, been following your work for many, many, many years, as really most of us have in functional medicine, and our paths have crossed in conferences and so forth over the years